跳至主要内容
临床试验/NCT05148728
NCT05148728Unknown不适用

Prospective Randomized Trial in Low Grade Bladder Tumors: Active Surveillance vs Endoscopic Fulguration.

Vall Hebron Insitut Recerca2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2021年12月15日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
2
主要终点
Progression rate

研究概览

简要总结

Biological behabiour of low grade bladder cancer tumors is well known. They have a very high rate of recurrences during their follow up but very low (less than 1%) risk of progression.

Until now, the gold standard of any bladder recurrence for this patients is performing an immediate transurethral ressection of the tumor.

This surgery has risk of complications and, due to the low risk of these subgroup of tumors, sometimes it becomes an overtreatment for the patients.

This is the reason why new conservative or less invasive surgeries are proposed to follow up and treat these patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Recurrent Ta-T1a (above muscularis mucosa) LOW GRADE bladder tumor
  • Accept cystoscopy surveillance
  • Main lession less than 10mm
  • Less than 7 lesions
  • Negative or low grade cytology
  • No solid aspect

排除标准

  • previous High grade bladder cancer tumors
  • previous Cis
  • previous Upper Urinary Tract tumor
  • previous pelvic radiotherapy
  • hematuria
  • meatal localisation

结局指标

主要结局

Progression rate

时间窗: two years

Number of patients that progress during the follow up

Complications rate

时间窗: two years

Number and grade of complications in both arms. Clavien Dindo Scale will be used

次要结局

  • recurrence rate(two years)
  • quality of life measured with CAVICAVENMI questionnaire(two years)

研究者

发起方
Vall Hebron Insitut Recerca
申办方类型
Network
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Active Surveillance vs in Office Fulguration for Low... | 临床试验